PRIMA
A retinal implant chip developed by Science Corporation that restores vision by replacing the function of degenerated photoreceptor cells in the retina. It is a form of visual neuroprosthesis.
Timeline (last 90 days)
Science Corporation's PRIMA vision-restoration chip has completed the first implantation in a Stargardt disease patient.
PRIMA is a retinal implant chip that restores vision by replacing the function of degenerated photoreceptors in the retina.
PRIMA uses a photovoltaic principle, powered by an infrared projector on the glasses and transmitting images.
Hodak positions PRIMA as Science Corporation's intermediate step toward broader BCI capabilities, rather than the endpoint.
Science Corporation may use PRIMA to validate its technology stack and clinical pathway, while the long-term goal remains a broader brain-computer interface.
PRIMA has improvements over Argus II in electrode density and signal processing, and in theory can provide higher spatial resolution.
All Facts (6)
PRIMA is a retinal implant chip that restores vision by replacing the function of degenerated photoreceptors in the retina.
50%UnverifiedPRIMA uses a photovoltaic principle, powered by an infrared projector on the glasses and transmitting images.
50%UnverifiedHodak positions PRIMA as Science Corporation's intermediate step toward broader BCI capabilities, rather than the endpoint.
50%UnverifiedPRIMA has improvements over Argus II in electrode density and signal processing, and in theory can provide higher spatial resolution.
50%UnverifiedScience Corporation's PRIMA vision-restoration chip has completed the first implantation in a Stargardt disease patient.
50%UnverifiedScience Corporation may use PRIMA to validate its technology stack and clinical pathway, while the long-term goal remains a broader brain-computer interface.
50%